Post COVID-19 Anosmia

Post COVID-19 Anosmia treatments - Anosmia treatments

Status

Recruiting

Phases

Unknown

Study type

Interventional

Source

JPRN

Registry ID

JPRN-UMIN000043537

Enrollment

200

Registered

2021-03-05

Start date

2021-01-01

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Anosmia

Interventions

Combination of local corticosteroids and antihistamines nasal spray Local corticosteroids nasal spray Antihistamines nasal spray Normal saline 0.2%

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: All adults with post-COVID-19 smell dysfunction

Exclusion criteria

Exclusion criteria: We excluded patients who already used nasal or systemic steroids or with previous chronic rhinological pathologies, patients with anosmia improved before COVID-19 recovery, pregnant women, or patients who did not complete the follow-up period

Design outcomes

Primary

Measure	Time frame
Anosmia improvement that was measured by Butanol threshold test and discrimination test	—

Countries

Africa

Contacts

Public ContactHosam Ahmad

Egypt Ministry of Health and population Internal Medicine and biomedical chemistry

hosam.refaei@yahoo.com01000638308

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026